NAC (N-Acetyl Cysteine)
A glutathione precursor with strong COPD/respiratory evidence and moderate evidence for OCD-spectrum symptom reduction (as adjunct, not monotherapy).
What it does
N-Acetyl Cysteine (NAC) at 1 to 2 g/day supports glutathione synthesis. Cochrane 2019 supports use for COPD/chronic-bronchitis exacerbation reduction. OCD-spectrum evidence is heterogeneous: 2024 meta-analysis modestly positive, 2023 Sarris RCT negative.
-
Respiratory mucus clearance / COPD exacerbations Strong evidence
Mucolytic via disulfide bond cleavage on mucin glycoproteins; reduces COPD/chronic-bronchitis exacerbations at 1200 mg/day. Long prescription history.
Sources: PMID 31107966
-
OCD symptom reduction (adjunct) Moderate evidence
Reduces Y-BOCS scores when added to SSRIs in moderate-to-severe OCD; significant benefit between weeks 5 and 8. Effect size modest, evidence mixed (one large 2023 Australian RCT was negative).
Sources: PMID 39376972
-
Trichotillomania (adults) Moderate evidence
Grant 2009 (n=50, 1200 to 2400 mg/day, 12 weeks): large reduction in hair-pulling vs placebo (P<.001). Pediatric RCT was NEGATIVE - adult evidence does not transfer to children.
Sources: PMID 19581567
-
Glutathione precursor Strong evidence
Provides cysteine (rate-limiting amino acid) for endogenous glutathione synthesis; FDA-approved IV antidote for acetaminophen-induced hepatotoxicity confirms the GSH-replenishment mechanism.
Sources: PMID 34201323 · N-Acetylcysteine StatPearls monograph
Top picks
- 1 Check on Amazon
NOW Foods
NAC 600 mg
600 mg per cap supports the 1200 to 2400 mg daily protocol.
- 2 Check on Amazon
Jarrow Formulas
NAC Sustain 600 mg
Sustained-release formulation.
- 3 Check on Amazon
Thorne
NAC 500 mg / Cysteplus
Practitioner-channel quality; clean inactives.
Affiliate disclosure: NootroWorld may earn a commission from qualifying Amazon purchases made through these links, at no extra cost to you. NootroScore and editorial rankings are calculated independently of any affiliate relationship. More on how we make money.
How to use it
- Dosage
- 600 to 2400 mg/day (typical 1200 mg split BID).
- Timing
- Divided 2x daily. OCD/trich studies titrated 1200 mg/day weeks 1-2 to 2400 mg/day weeks 3+.
- With food
- Yes
- Onset
- Respiratory 4 to 12 weeks; OCD/trich 8 to 12 weeks minimum (effect emerges weeks 5 to 8).
What to look for
FAQ
- Why was it briefly hard to find on Amazon?
- FDA briefly questioned its supplement-vs-drug status in 2020-2021. Settled in August 2022 with enforcement discretion; now widely available again.
- Does it work for OCD as monotherapy?
- No. Frame as adjunct to SSRIs. Evidence is heterogeneous and one large 2023 RCT was negative.